000 | 01926 a2200565 4500 | ||
---|---|---|---|
005 | 20250516212746.0 | ||
264 | 0 | _c20150611 | |
008 | 201506s 0 0 eng d | ||
022 | _a1399-5448 | ||
024 | 7 |
_a10.1111/pedi.12151 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLundgren, Markus | |
245 | 0 | 0 |
_aReduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up. _h[electronic resource] |
260 |
_bPediatric diabetes _cNov 2014 |
||
300 |
_a494-501 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
650 | 0 | 4 |
_aDiabetic Ketoacidosis _xepidemiology |
650 | 0 | 4 | _aEarly Diagnosis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperglycemia _xprevention & control |
650 | 0 | 4 |
_aHypoglycemia _xprevention & control |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aInsulin _xtherapeutic use |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aSweden _xepidemiology |
700 | 1 | _aSahlin, Åsa | |
700 | 1 | _aSvensson, Camilla | |
700 | 1 | _aCarlsson, Annelie | |
700 | 1 | _aCedervall, Elisabeth | |
700 | 1 | _aJönsson, Björn | |
700 | 1 | _aJönsson, Ida | |
700 | 1 | _aLarsson, Karin | |
700 | 1 | _aLernmark, Åke | |
700 | 1 | _aNeiderud, Jan | |
700 | 1 | _aVigård, Tore | |
700 | 1 | _aElding Larsson, Helena | |
773 | 0 |
_tPediatric diabetes _gvol. 15 _gno. 7 _gp. 494-501 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/pedi.12151 _zAvailable from publisher's website |
999 |
_c23821557 _d23821557 |